BAX and B-cell chronic lymphocytic leukemia: In vitro treatment of bortezomib in B-cell lines and primary chronic lymphocytic leukemia (CLL) cells has shown to induce and stabilize the Bax accumulation, its translocation to mitochondria and oligomerization (Liu et al., 2008).